192 related articles for article (PubMed ID: 8872148)
21. Transthyretin immunoreactivity in choroid plexus neoplasms and brain metastases.
Albrecht S; Rouah E; Becker LE; Bruner J
Mod Pathol; 1991 Sep; 4(5):610-4. PubMed ID: 1758873
[TBL] [Abstract][Full Text] [Related]
22. Does choroid plexus tumour differ with age?
Sampath S; Nitin G; Yasha TC; Chandramouli BA; Devi BI; Kovoor JM
Br J Neurosurg; 2008 Jun; 22(3):373-88. PubMed ID: 18568726
[TBL] [Abstract][Full Text] [Related]
23. MIB-1 immunoreactivity in craniopharyngiomas: a clinico-pathological analysis.
Duò D; Gasverde S; Benech F; Zenga F; Giordana MT
Clin Neuropathol; 2003; 22(5):229-34. PubMed ID: 14531547
[TBL] [Abstract][Full Text] [Related]
24. Cytokeratin 7 and 20 expression in choroid plexus tumors: utility in differentiating these neoplasms from metastatic carcinomas.
Gyure KA; Morrison AL
Mod Pathol; 2000 Jun; 13(6):638-43. PubMed ID: 10874668
[TBL] [Abstract][Full Text] [Related]
25. Diffuse leptomeningeal seeding from benign choroid plexus papilloma.
Ortega-Martínez M; Cabezudo-Artero JM; Fernández-Portales I; Pimentel JJ; Gómez de Tejada R
Acta Neurochir (Wien); 2007 Dec; 149(12):1229-36; discussion 1236-7. PubMed ID: 17924056
[TBL] [Abstract][Full Text] [Related]
26. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
[TBL] [Abstract][Full Text] [Related]
27. MIB-1 labeling index as a prognostic indicator for survival in patients with FIGO stage IB squamous cell carcinoma of the cervix.
Ho DM; Hsu CY; Chiang H
Gynecol Oncol; 2000 Jan; 76(1):97-102. PubMed ID: 10620448
[TBL] [Abstract][Full Text] [Related]
28. Image cytometric comparison of proliferating cell nuclear antigen and MIB-1 staining in hepatocellular carcinoma and adjacent liver tissue.
Wells SJ; DeRose PB; Cohen C
Cytometry; 1996 Sep; 26(3):198-203. PubMed ID: 8889391
[TBL] [Abstract][Full Text] [Related]
29. Myxopapillary ependymomas: a clinicopathologic study of 14 cases including MIB-1 and p53 immunoreactivity.
Prayson RA
Mod Pathol; 1997 Apr; 10(4):304-10. PubMed ID: 9110291
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis.
Yacoub L; Goldman H; Odze RD
Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315
[TBL] [Abstract][Full Text] [Related]
31. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
Ozen O; Demirhan B; Altinörs N
Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
[TBL] [Abstract][Full Text] [Related]
32. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
[TBL] [Abstract][Full Text] [Related]
33. Comparison of quantitative and semiquantitative methods of assessing MIB-1 with the S-phase fraction in breast carcinoma.
MacGrogan G; Jollet I; Huet S; Sierankowski G; Picot V; Bonichon F; Coindre JM
Mod Pathol; 1997 Aug; 10(8):769-76. PubMed ID: 9267818
[TBL] [Abstract][Full Text] [Related]
34. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors.
Patsouris E; Stocker U; Kallmeyer V; Keiditsch E; Mehraein P; Stavrou D
Anticancer Res; 1988; 8(4):537-44. PubMed ID: 3052245
[TBL] [Abstract][Full Text] [Related]
35. Prognostic implications of atypical histologic features in choroid plexus papilloma.
Jeibmann A; Hasselblatt M; Gerss J; Wrede B; Egensperger R; Beschorner R; Hans VH; Rickert CH; Wolff JE; Paulus W
J Neuropathol Exp Neurol; 2006 Nov; 65(11):1069-73. PubMed ID: 17086103
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas.
Prayson RA; Mohan DS; Song P; Suh JH
Ann Diagn Pathol; 2000 Aug; 4(4):218-27. PubMed ID: 10982299
[TBL] [Abstract][Full Text] [Related]
37. Tumour cell proliferation rate as determined by MIB-1 antibody in Wilms' tumour.
Juszkiewicz P; Tuziak T; Zbisławski W; Liebhard M; Chosia M
Pol J Pathol; 1997; 48(2):113-9. PubMed ID: 9278108
[TBL] [Abstract][Full Text] [Related]
38. A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters.
McKeever PE; Ross DA; Strawderman MS; Brunberg JA; Greenberg HS; Junck L
J Neuropathol Exp Neurol; 1997 Jul; 56(7):798-805. PubMed ID: 9210876
[TBL] [Abstract][Full Text] [Related]
39. The standard isoform of CD44 is preferentially expressed in atypical papillomas and carcinomas of the choroid plexus.
Varga Z; Vajtai I; Aguzzi A
Pathol Res Pract; 1996 Dec; 192(12):1225-31. PubMed ID: 9182293
[TBL] [Abstract][Full Text] [Related]
40. DNA methylation patterns of the CDH1, RARB, and SFN genes in choroid plexus tumors.
Losi-Guembarovski R; Kuasne H; Guembarovski AL; Rainho CA; Cólus IM
Cancer Genet Cytogenet; 2007 Dec; 179(2):140-5. PubMed ID: 18036402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
